HLB Life Science ranked among the top searched stocks on 11 days over the past month.
As of 9:30 AM on the 29th, HLB Life Science is trading at 31,100 KRW, up 3.15% from the previous day. This marks a 65.43% increase compared to September 1. HLB Life Science is known as an engineering service company related to energy saving.
Over the past five days, individual investors have sold a net 100,259 shares, while foreigners and institutions have bought a net 89,835 shares and 178 shares, respectively.
On September 21, HLB Life Science became a market issue with a 21% increase following the Phase 3 clinical trial results of 'Rivoceranib'.
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
